Methyl 4-bromo-3,5-dichlorobenzoate, 97.0%, 5g

1-(2-(4-Butylphenyl)ethynyl)-4-methoxybenzene, 97.0%, 25g

5-Bromo-8-methyl-1,7-naphthyridine, 98%, 500mg

((4'-methoxy-[1,1'-biphenyl]-4-yl)sulfonyl)glycine, 95.0%, 1g

1,2-Dichloroéthane, min.99%, pour la synthèse, 2,5 L, emballage en verre

3,6-Dibromo-2-methylbenzaldehyde, 95.0%, 100mg

2-Amino-3-cyclopentylpropanoic acid, 95.0%, 5g

5-Ethynyl-2-methylpyridine hydrochloride, 98%, 100mg

3,3-Difluorocyclobutanecarboxylic Acid>98.0%(GC)(T)200mg

2-Methylimidazo[1,2-a]pyridine, 97.0%, 1g

3-Bromo-2-(difluoromethoxy)-5-fluoropyridine, 98%, 250mg

Nifuroxazide, 95%, 500g

4-Amino-1-((2R,4S,5R)-5-(((tert-butyldimethylsilyl)oxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-5-iodopyrimidin-2(1H)-one, 97%, 1g